Temiwunmi Shobanke

Temiwunmi Akinmuleya Shobanke is a Program Manager at the Institute for Clinical and Economic Review (ICER) since July 2024, responsible for coordinating health technology assessment reviews for new drug therapies with a focus on health policy and equity. Previously, Temiwunmi held roles as a Graduate Teaching Fellow and Research Assistant at Harvard T.H. Chan School of Public Health from August 2022 to August 2024, conducting literature reviews and case studies in public health leadership. Additional experience includes working as a Healthcare Consultant at Analysis Group in mid-2023, serving as a Medical Strategy and Regulatory Affairs Associate at Sanofi from July 2021 to July 2022, and practicing as a Clinical Pharmacist at National Orthopaedic Hospital Igbobi Lagos from September 2019 to August 2020. Temiwunmi earned a Master of Science in Global Health and Population from Harvard T.H. Chan School of Public Health in May 2024, following a Bachelor of Pharmacy in Pharmaceutical Sciences from the University of Ibadan in 2019.